multiple pretreated and refractory …….ibrutinib?

This topic contains 3 replies, has 4 voices, and was last updated by  Anonymous 10 years, 8 months ago.

Viewing 4 posts - 1 through 4 (of 4 total)
  • Author
    Posts
  • 17th April 2014 at 2:18 pm #114572

    peral
    Participant

    Hi there,

    just heard from a german private clinic using ibrutinib for highly pretreated refractory MM off-label (last-line therapy) – would be great to have some feedback on ibrutinib – would this be worth it to go for?

    Thanks for your feedback in advance,

    peral

    17th April 2014 at 9:45 pm #114578

    tonyf
    Participant

    Just read the BBC pages, I think ibrutinib is a drug designed to fight leukaemia evidently will be in use in Wales by end of the year. Don’t know what the implications are for myeloma.
    Regards
    Tony F

    18th April 2014 at 7:30 am #114582

    dickb
    Participant

    Suggest you look at this link
    http://www.bbc.com/news/uk-wales-27073711

    • This reply was modified 10 years, 9 months ago by  dickb.
    28th April 2014 at 9:51 am #114712

    Anonymous

    Well, ibrutinib has potential antitumor activities in multiple myeloma (MM), targeting both tumor cells and their supporting microenvironment.

  • Author
    Posts
Viewing 4 posts - 1 through 4 (of 4 total)

The topic ‘multiple pretreated and refractory …….ibrutinib?’ is closed to new replies.